Abstract
This study investigated three-dimensional (3D) texture as a possible diagnostic marker of Alzheimer’s disease (AD). T1-weighted magnetic resonance (MR) images were obtained from 17 AD patients and 17 age and gender-matched healthy controls. 3D texture features were extracted from the circular 3D ROIs placed using a semi-automated technique in the hippocampus and entorhinal cortex. We found that classification accuracies based on texture analysis of the ROIs varied from 64.3% to 96.4% due to different ROI selection, feature extraction and selection options, and that most 3D texture features selected were correlated with the mini-mental state examination (MMSE) scores. The results indicated that 3D texture could detect the subtle texture differences between tissues in AD patients and normal controls, and texture features of MR images in the hippocampus and entorhinal cortex might be related to the severity of AD cognitive impairment. These results suggest that 3D texture might be a useful aid in AD diagnosis.
Similar content being viewed by others
References
Alzheimer’s Association (2010) Alzheimer’s disease facts and figures. Includes a Special Report on Race, Ethnicity and Alzheimer’s Disease. 2010.
Boniha, L., Kobayashi, E., Castellano, G., Coelho, G., Tinois, E., Cendes, F., et al. (2003). Texture analysis of hippocampal sclerosis. Epilepsia, 44, 1546–1550.
China Alzheimer’s Project, http://www.memory360.org/en/. Accessed in Sept., 2011.
Colliot, O., Chételat, G., Chupin, M., Desgranges, B., Magnin, B., Benali, H., et al. (2008). Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology, 248, 194–201.
Cummings, J. L., Vinters, H. V., Cole, G. M., & Khachaturian, Z. S. (1998). Alzheimer’s disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology, 51(supl 1), 2–17.
Dash, M., & Liu, H. (1997). Feature selection for classification. Elsevier Science Inc., http://www-east.elsevier.com/ida/browse/0103/ida00013/article.htm/
Delacourte, A., David, J. P., Sergeant, N., Buee, L., Wattez, A., Vermersch, P., et al. (1999). The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease. Neurology, 52, 1158–1165.
Desikan, R. S., Cabral, H. J., Hess, C. P., Dillon, W. P., Glastonbury, C. M., Weiner, M. W., et al. (2009). Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer’s disease. Brain, 132(8), 2048–2057.
Drzezga, A., Lautenschlage, Y. U., Siebner, H., Riemenschneider, M., Willoch, F., Minoshima, S., et al. (2003). Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer’s disease: a PET follow-up study. European Journal of Nuclear Medicine and Molecular Imaging, 30(8), 1104–1113.
Du, A. T., Schuff, N., Zhu, X. P., Jagust, W. J., Miller, B. L., Reed, B. R., et al. (2003). Atrophy rates of entorhinal cortex in AD and normal aging. Neurology, 60, 481–486.
El-Baz, A., Casanova, M. F., Gimel’farb, G., Mott, M., & Switala, A. E. (2007). Autism diagnostics by 3D texture analysis of cerebral white matter gyrifications. Medical Image Computing and Computer-Assisted Intervention, 10(Pt 2), 882–890.
Folstein, M., Folstein, S., & McHugh, P. (1975). “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
Fox, N. C., & Freeborough, P. A. (1997). Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer’s disease. Journal of Magnetic Resonance Imaging, 7, 1069–1075.
Fox, N. C., Scahill, R. I., Crum, W. R., & Rossor, M. N. (1999). Correlation between rates of brain atrophy and cognitive decline in AD. Neurology, 52, 1687–1689.
Fox, N. C., Cousens, S., Scahill, R., Harvey, R. J., & Rossor, M. N. (2000). Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer’s disease. Archives of Neurology, 57, 339–443.
Freeborough, P. A., & Fox, N. C. (1998). MR image texture analysis applied to the diagnosis and tracking of Alzheimer’s disease. IEEE Transactions on Medical Imaging, 17(3), 475–479.
Galloway, M. (1975). Texture analysis using gray level run lengths. Computer Graphics and Image Processing, 4, 171–179.
Gerardin, E., Chetelat, G., Chupin, M., Cuingnet, R., Desgranges, B., Kim, H. S., et al. (2009). Multidimensional classification of hippocampal shape features discriminates Alzheimer’s disease and mild cognitive impairment from normal aging. NeuroImage, 47(4), 1476–1486.
Haralick, R. M., Shanmugam, K., & Dinstein, J. (1973). Textural features for image classification. IEEE Transactions on Systems, Man, and Cybernetics, 6, 610–621.
Harrison, L., Dastidar, P., Eskola, H., Järvenpää, R., Pertovaara, H., Luukkaala, T., et al. (2008). Texture analysis on MRI images of non-Hodgkin lymphoma. Computers in Biology and Medicine, 38, 519–524.
Hughes, C. P., Berg, L., Danziger, W. L., Coben, L. A., & Martin, R. L. (1982). A new clinical scale for the staging of dementia. British Journal of Psychiatry, 240, 566–572.
Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., et al. (1998). Rate of medial temporal lobe atrophy in typical aging and Alzheimer’s disease. Neurology, 51(4), 993–999.
Jack, C. R., Shiung, M. M., Gunter, J. L., O’Brien, P. C., Weigand, S. D., Knopman, D. S., et al. (2004). Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology, 62(4), 591–600.
Jack, C. R., Weigand, S. D., Shiung, M. M., Przybelski, S. A., O’Brien, P. C., Gunter, J. L., et al. (2008). Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology, 70(19 Pt 2), 1740–1752.
Kaeriyama, T., Kodama, N., Shimada, T., & Fukumoto, I. (2002). Application of run length matrix to magnetic resonance imaging diagnosis of Alzheimer-type dementia. Nippon Hoshasen Gijutsu Gakkai Zasshi, 58(11), 1502–1508.
Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., et al. (2008). Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurology, 7(9), 812–826.
Karas, G. B., Burton, E. J., Rombouts, S. A., Van Schijndel, R. A., O’Brien, J. T., Scheltens, P., et al. (2003). A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry. NeuroImage, 18, 895–907.
Kesslak, J. P., Nalcioglu, O., & Cotman, C. W. (1991). Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer’s disease. Neurology, 41, 51–54.
Klöppel, S., Stonnington, C. M., Chu, C., Draganski, B., Scahill, R. I., Rohrer, J. D., et al. (2008). Automatic classification of MR scans in Alzheimer’s disease. Brain, 131(Pt 3), 681–689.
Kovalev, V. A., Kruggel, F., Gertz, H. J., & Yves von Cramon, D. (2001). Three-dimensional texture analysis of MRI brain datasets. IEEE Transactions on Medical Imaging, 20(5), 424–433.
Kumar, S. V. B., Mullick, R., & Patil, U. (2005). Textural content in 3T MR: An image-based marker for Alzheimer’s disease. Proc. of SPIE Medical Imaging.
Liu, Y., Teverovskiy, L., Carmichael, O., Kikinis, R., Shenton, M., Carter, C. S., et al. (2004). Discriminative MR image feature analysis for automatic schizophrenia and Alzheimer’s disease classification (pp. 393–400). Heidelberg: Springer. MICCAI 2004 (LNCS 3216).
Mathias, J. M., Tofts, P. S., & Losseff, N. A. (1999). Texture analysis of spinal cord pathology in multiple sclerosis. Magnetic Resonance in Medicine, 42, 929–935.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34(7), 939–944.
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997). Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Annals of Neurology, 42, 85–94.
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412–2414.
Mucciardi, A. N., & Gose, E. E. (1971). A comparison of seven techniques for choosing subsets of patter recognition properties. IEEE Transactions on Computers, c-20(9), 1023–1031.
Namer, I. J., Yu, O., Mauss, Y., & Chambron, J. (2001). Existence of contralateral abnormalities revealed by texture analysis in unilateral intractable hippocampal epilepsy. Magnetic Resonance Imaging, 19, 1305–1310.
National Institute of Ageing (NIA), NIH (2009). http://www.nia.nih.gov/Alzheimers/Publications/Unraveling/Part2/hallmarks.htm.
Petrella, J. R., Coleman, R. E., & Doraiswamy, P. M. (2003). Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology, 226(2), 315–336.
Rangayyan, R. M., Banik, S., & Desautels, J. E. (2010). Computer-aided detection of architectural distortion in prior mammograms of interval cancer. Journal of Digital Imaging. 2010 Feb 2.
Sayeed, A., Petrou, M., Spyrou, N., Kadyrov, A., & Spinks, T. (2002). Diagnostic features of Alzheimer’s disease extracted from PET sinograms. Physics in Medicine and Biology, 47(1), 137–148.
Saeed, N., & Piri, B. K. (2002). Cerebellum segmentation employing texture properties and knowledge based image processing: applied to normal adult controls and patients. Magnetic Resonance Imaging, 20, 425–429.
Schürman, J. (1996). Pattern classification. John Wiley & Sons.
Silverman, D. H., Small, G. W., Chang, C. Y., Lu, C. S., Kung De Aburto, M. A., Chen, W., et al. (2001). Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA, 286, 2120–2127.
Small, G. W., Ercoli, L. M., Silverman, D. H., Huang, S. C., Komo, S., Bookheimer, S. Y., et al. (2000). Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease. Proceedings of the National Academy of Sciences United States of America, 87, 6037–6042.
Strzelecki, M., Materka, A., & Szczypinski, P. M. (2006). MaZda. In Texture analysis for magnetic resonance imaging (pp. 105–111). Prague, Czech: Med4publishing, 2006.
Szczypinski, P. M., Strzelecki, M., Materka, A., & Klepaczko, A. (2009). MaZda—A software package for image texture analysis. Computer Methods and Programs in Biomedicine, 94, 66–76.
Zhang, J., Tong, L. Z., Wang, L., & Li, N. (2008). Texture analysis of multiple sclerosis: a comparative study. Magnetic Resonance Imaging, 26(8), 1160–1166.
Zhang, Y., Zhu, H., Ferrari, R., Wei, X., Eliasziw, M., Metz, L. M., et al. (2003). Texture analysis of MR images of minocycline treated MS patients, MICCAI (LNCS 2878) (pp. 786–793). Heidelberg: Springer.
Acknowledgements
The project was partially supported by the Program for New Century Excellent Talents in University (NCET-07-0568), the Natural Science Foundation of China (Grant No. 30670575) and Beijing Natural Science Foundation (Grant No. 3073015).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, J., Yu, C., Jiang, G. et al. 3D texture analysis on MRI images of Alzheimer’s disease. Brain Imaging and Behavior 6, 61–69 (2012). https://doi.org/10.1007/s11682-011-9142-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-011-9142-3